Tamsulosin Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Tamsulosin Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

TAMSULOSIN HYDROCHLORIDE DESCRIPTION




Tamsulosin Hydrochloride



CLINICAL PHARMACOLOGY





PHARMACOKINETICS



Absorption


Effect of Food


Tamsulosin Hydrochloride



Pharmacokinetic ParameterLight BreakfastFastedLight BreakfastHigh-Fat BreakfastFasted
Distribution



Metabolism
Drug-Drug InteractionsCytochrome P450 Inhibition


Excretion




Special Populations

Geriatrics (Age)


Renal Dysfunction


Hepatic Dysfunction


Drug-Drug Interactions

Nifedipine, Atenolol, Enalapril


Warfarin


Digoxin and Theophylline


Furosemide
The pharmacokinetic and pharmacodynamic interaction between Flomax(tamsulosin hydrochloride) capsules 0.8 mg/day (steady-state) and furosemide 20 mg intravenously (single dose) was evaluated in ten healthy volunteers (age range 21-40 years). FLOMAX capsules had no effect on the pharmacodynamics (excretion of electrolytes) of furosemide. While furosemide produced an 11% to 12% reduction in tamsulosin hydrochloride Cmax and AUC, these changes are expected to be clinically insignificant and do not require adjustment of the FLOMAX capsules dosage.

Cytochrome P450 Inhibition:
Cimetidine
The effects of cimetidine at the highest recommended dose (400 mg every six hours for six days) on the pharmacokinetics of a single FLOMAX capsule 0.4 mg dose was investigated in ten healthy volunteers (age range 21-38 years). Treatment with cimetidine resulted in a significant decrease (26%) in the clearance of tamsulosin hydrochloride, which resulted in a moderate increase in tamsulosin hydrochloride AUC (44%). Therefore, FLOMAX capsules should be used with caution in combination with cimetidine, particularly at doses higher than 0.4 mg.
Strong Inhibitors of CYP3A4 or CYP2D6
The effects of ketoconazole (a strong inhibitor of CYP3A4) at 400 mg every day on the pharmacokinetics of a single FLOMAX capsule 0.4 mg dose was investigated in 24 healthy volunteers (age range from 23 to 47 years). Treatment with ketoconazole resulted in a Cmax and AUC that increased by a factor of 2.2 and 2.8, respectively. Therefore, FLOMAX 0.4 mg capsules should be used with caution in combination with strong inhibitors of CYP3A4. Doses above 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole).
The effects of paroxetine (a strong inhibitor of CYP2D6) at 20 mg every day on the pharmacokinetics of a single FLOMAX capsule 0.4 mg dose was investigated in 23 healthy volunteers (age range from 23 to 48 years). Treatment with paroxetine resulted in a Cmax and AUC that increased by a factor of 1.3 and 1.6, respectively. Therefore, FLOMAX capsules should be used with caution in combination with strong inhibitors of CYP2D6, particularly at doses higher than 0.4 mg (e.g., 0.8 mg).

CLINICAL STUDIES





Total AUA Symptom ScorePeak Urine Flow RateMean Baseline ValueMean ChangeMean Baseline ValueMean ChangeStudy 1Study 2


Tamsulosin Hydrochloride







Tamsulosin Hydrochloride







Tamsulosin Hydrochloride









Tamsulosin Hydrochloride








TAMSULOSIN HYDROCHLORIDE CONTRAINDICATIONS



INDICATIONS & USAGE



WARNINGS

ADVERSE REACTIONS


PRECAUTIONS, Information for Patients

PRECAUTIONS

General




CLINICAL PHARMACOLOGYDrug-Drug Interactions
WARNINGS

Drug-Drug Interactions

INFORMATION FOR PATIENTS






LABORATORY TESTS



PREGNANCY

Teratogenic Effects



GERIATRIC USE

CLINICAL PHARMACOLOGY, PharmacokineticsSpecial PopulationsGeriatrics (Age))

NURSING MOTHERS



PEDIATRIC USE



CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY








TAMSULOSIN HYDROCHLORIDE ADVERSE REACTIONS



BODY SYSTEM/ ADVERSE EVENTFLOMAX CAPSULES GROUPSPLACEBO0.4 mg n=5020.8 mg n=492n=493BODY AS WHOLENERVOUS SYSTEMRESPIRATORY SYSTEMDIGESTIVE SYSTEMUROGENITAL SYSTEMSPECIAL SENSES



WARNINGS


Post-Marketing Experience

PRECAUTIONS, General

OVERDOSAGE

WARNINGSADVERSE REACTIONS


DOSAGE & ADMINISTRATION







HOW SUPPLIED













INFORMATION FOR PATIENTS

Tamsulosin Hydrochloride Capsules USP*, 0.4 mg


What is tamsulosin hydrochloride?


  • ●     Tamsulosin hydrochloride capsules are not for women.
  • ●     Tamsulosin hydrochloride capsules are not for children.
Who should not take tamsulosin hydrochloride capsules, USP?


What should I tell my doctor before using tamsulosin hydrochloride capsules, USP?
Before taking tamsulosin hydrochloride capsules, USP tell your doctor about all your medical conditions including:

  • ●     any kidney or liver problems.
  • ●     any history of low blood pressure.
  • ●     any allergies to sulfa or any other medicines.
  • ●     if you are planning to have cataract surgery.
Tell your doctor about all the medicines you take including:
  • ●     any prescription medicines, including blood pressure medicines.
  • ●     any non-prescription medicines, including vitamins and herbal supplements.




How should I take tamsulosin hydrochloride capsules, USP?
  • ●     Take tamsulosin hydrochloride capsules exactly as prescribed by your doctor.
  • ●     Do not crush, chew, or open tamsulosin hydrochloride capsules.
  • ●     Take tamsulosin hydrochloride capsules one time each day, about 30 minutes after the same meal each day. For example, you may take tamsulosin hydrochloride capsules 30 minutes after dinner each day.
  • ●     If you miss a dose of tamsulosin hydrochloride capsules, take it as soon as you remember. If you miss your dose for the whole day, continue with your next dose on your regular schedule. Do not take two doses at the same time.
  • ●     If you stop or forget to take tamsulosin hydrochloride capsules for several days, talk with your doctor before starting again.
  • ●     If you take more tamsulosin hydrochloride capsules than prescribed, call your doctor right away.
What are the possible side effects of tamsulosin hydrochloride capsules, USP?

  •      Decreased blood pressure when changing positions.Tamsulosin hydrochloride capsules may cause a sudden drop in blood pressure upon standing, especially after the first dose or when changing doses.

  • ●     fainting
  • ●     dizziness
  • ●     lightheadedness


  •      Allergic reactions.Make your doctor aware of any allergic reactions you may experience while taking tamsulosin hydrochloride.

  • ●     rash
  • ●     itching
  • ●     hives

  • ●     swelling of face, tongue, or throat
  • ●     difficulty breathing
Get medical help right away if you have swelling of the face, tongue or throat, or difficulty breathing.

  •      A painful erection that will not go away.Tamsulosin hydrochloride capsules can cause a painful erection (priapism), which cannot be relieved by having sex. If this happens, get medical help right away. If priapism is not treated, you may not be able to get an erection in the future.
  •      Eye problems during cataract surgery.During cataract surgery, a condition called intraoperative floppy iris syndrome (IFIS) can happen if you take or have taken tamsulosin hydrochloride capsules. If you need to have cataract surgery, be sure to tell your surgeon if you take or have taken tamsulosin hydrochloride capsules.

  • ●     runny nose
  • ●     dizziness
  • ●     decreased semen




What should I avoid while taking tamsulosin hydrochloride capsules, USP?


How do I store tamsulosin hydrochloride capsules, USP?


Keep tamsulosin hydrochloride capsules, USP and all medicines out of the reach of children.

General information








What are the ingredients in tamsulosin hydrochloride capsules, USP?
  • ●     Active Ingredient: tamsulosin hydrochloride
  • ●     Inactive Ingredients: microcrystalline cellulose, magnesium stearate, methacrylic acid copolymer dispersion, talc, triethyl citrate, FD and C blue # 1, FD and C red # 40, FD and C yellow # 10, titanium dioxide, gelatin, shellac, dehydrated alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, strong ammonia solution, black iron oxide and potassium hydroxide     












PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Tamsulosin Hydrochloride

Tamsulosin Hydrochloride

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL










Tamsulosin Hydrochloride

Tamsulosin Hydrochloride CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-401(NDC:64679-516)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
TAMSULOSIN HYDROCHLORIDE TAMSULOSIN 0.4 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
triacetin
CALCIUM STEARATE
talc
FD&C BLUE NO. 2
titanium dioxide
FERRIC OXIDE YELLOW
GELATIN

Product Characteristics

Color Size Imprint Code Shape
green 2 mm W;516 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-401-02 30 in 1 BLISTER PACK
2 NDC:49349-401-24 200 in 1 CANISTER

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078938 2011-07-20


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.